U.S. Health Insurers Step Up Prior Authorization Reforms Amid Industry Pressure
By Connor Hart
U.S. health insurers are accelerating efforts to streamline prior authorization requirements, with UnitedHealthcare and Aetna on Friday detailing progress toward industry commitments aimed at reducing administrative burdens and speeding patients' access to care.
UnitedHealthcare said more than half of its prior authorization volume will be incorporated into a standardized electronic submission process, with that share expected to exceed 70% by the end of 2026.
And Aetna, a unit of CVS Health, said it has already standardized 88% of its prior authorization volume. The company also said it is processing 83% of requests in real time, ahead of a 2027 goal set by insurers, and that more than 95% of eligible requests are approved within 24 hours.
Both companies emphasized the use of automation and digital tools to reduce administrative friction for providers. Aetna said it has eliminated more than 1 million provider calls through automation, while UnitedHealthcare highlighted efforts to reduce documentation requirements and limit the need for follow-up information.
The updates come as insurers face sustained scrutiny over prior authorization practices that can delay or block necessary care, The Wall Street Journal previously reported. The industry pledged last year to standardize electronic submissions and deliver at least 80% of decisions in real time by 2027, part of a broader push to ease administrative burdens and improve transparency.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
April 24, 2026 08:22 ET (12:22 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
